U-M’s ALS Center of Excellence is a Research Site for the Amylyx Pharmaceuticals Drug Preliminary data showing an Amylyx Pharmaceuticals drug as a promising new therapy in slowing the progression of ALS was published in The Wall … [Read more...]
Promising Results from Clinical Drug Trial Covered by The Wall Street Journal
U-M ALS Center of Excellence Participates in National Clinical Drug Trial
The University of Michigan ALS Center of Excellence will be a site in the upcoming Healey Center Platform Trial for ALS. A collaboration with the Northeast ALS Consortium (NEALS) and Sean M. Healey & AMG Center for ALS at … [Read more...]
